Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Aging Cell|May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in MulticohortsZhiyu Wu, Shanshan Wu, Shuyao Song, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Aging Cell|May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in MulticohortsZhiyu Wu, Shanshan Wu, Shuyao Song, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Pageof 30